Breast Health in Chinese American Women
|ClinicalTrials.gov Identifier: NCT01292200|
Recruitment Status : Completed
First Posted : February 9, 2011
Last Update Posted : July 2, 2017
|Condition or disease||Intervention/treatment|
|Breast Cancer||Behavioral: watch DVD and small group discussion Behavioral: watch DVD|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||954 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A RCT to Promote Mammography Adherence Among Chinese Immigrant Women|
|Study Start Date :||July 2010|
|Primary Completion Date :||December 21, 2016|
|Study Completion Date :||December 21, 2016|
Experimental: watch DVD and small group discussion
Participants will watch the video in a group and discuss the video.
Behavioral: watch DVD and small group discussion
Women in the small-group discussion mode will be called by their community educators to determine possible dates, times, and places for group meetings. The small group sessions will be conducted near the participants' homes. Each small-group will consist of 5-10 participants who will first view a 20-minute video together and then discuss the content of the video as well as their barriers to screening for about 30 minutes. A community educator and an RA at the study site will facilitate the discussion in Chinese languages according to a structured guide.
Placebo Comparator: watch video only
watch a 22 minutes long video at home by herself.
Behavioral: watch DVD
Women in the single video mode will receive a cultural video along with an information sheet on local free and low-cost screening programs by mail.
- 3rd interview about receipt of mammography screening [ Time Frame: 6-month post-intervention ]Measure the effect of small group video discussion on mammography screening adherence.
- 4th interview about receipt of mammography screening [ Time Frame: 21-month post-intervention ]Measure the effect of small group video discussion on repeated mammography screening adherence.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01292200
|United States, California|
|Los Angeles, California, United States, 90095|
|United States, District of Columbia|
|Washington, D.C., District of Columbia, United States, 20007|
|United States, Pennsylvania|
|Philadelphia, Pennsylvania, United States, 19122|
|Principal Investigator:||Judy (Huei-Yu) Wang, Ph.D.||Georgetown University|